HealthEquity, Inc. (NASDAQ:HQY) Receives $110.71 Consensus Target Price from Brokerages

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been assigned a consensus rating of “Moderate Buy” from the fourteen analysts that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $110.71.

Several analysts have issued reports on HQY shares. The Goldman Sachs Group initiated coverage on shares of HealthEquity in a research report on Friday, November 15th. They issued a “neutral” rating and a $108.00 price target on the stock. JMP Securities lifted their target price on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a research report on Tuesday. Bank of America boosted their price target on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research note on Wednesday, November 13th. Barrington Research raised their price objective on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Monday, December 2nd. Finally, Royal Bank of Canada boosted their price objective on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday.

HealthEquity Trading Up 0.7 %

Shares of HealthEquity stock opened at $95.62 on Wednesday. HealthEquity has a 1 year low of $62.10 and a 1 year high of $105.82. The company’s fifty day simple moving average is $94.06 and its 200-day simple moving average is $84.19. The company has a market cap of $8.29 billion, a price-to-earnings ratio of 87.72, a PEG ratio of 1.10 and a beta of 0.55. The company has a current ratio of 3.20, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the transaction, the director now owns 19,061 shares in the company, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Frank Corvino sold 1,039 shares of the business’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total value of $99,847.90. Following the completion of the transaction, the director now directly owns 3,784 shares in the company, valued at approximately $363,642.40. This represents a 21.54 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 43,786 shares of company stock valued at $4,140,387. 2.20% of the stock is owned by insiders.

Institutional Investors Weigh In On HealthEquity

Several hedge funds and other institutional investors have recently added to or reduced their stakes in HQY. International Assets Investment Management LLC acquired a new position in shares of HealthEquity during the second quarter worth approximately $35,000. Paladin Wealth LLC bought a new position in HealthEquity in the 3rd quarter worth approximately $39,000. Point72 Asia Singapore Pte. Ltd. bought a new position in HealthEquity in the 2nd quarter worth approximately $73,000. GAMMA Investing LLC lifted its holdings in HealthEquity by 57.8% during the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock worth $77,000 after buying an additional 344 shares in the last quarter. Finally, Quarry LP boosted its position in HealthEquity by 418.8% in the 3rd quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after buying an additional 1,089 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.